Axial Spondyloarthritis Diagnosis Delay in India: Factors Contributing to Late Presentation and Functional Impact
Axial Spondyloarthritis (axSpA) is a chronic inflammatory disease. It mainly affects the spine and sacroiliac joints. However, many patients in India face long delays before receiving a correct diagnosis.
Doctors often identify axSpA after 6 to 10 years of symptom onset. This delay happens for several important reasons.
First, patients and general physicians commonly mistake early symptoms for ordinary back pain. Moreover, lower back pain is very common in India, so doctors frequently treat it with painkillers instead of referring patients to specialists.
Furthermore, India has a limited number of rheumatologists. As a result, patients in rural and smaller cities wait for months or years to see an expert. Additionally, low awareness about axSpA among healthcare workers leads to repeated misdiagnoses.
Economic challenges also play a major role. Many patients avoid costly tests like MRI because of financial constraints. Therefore, they continue to suffer without proper diagnosis.
The functional impact of this delay is severe. Patients experience increasing pain and stiffness over time. Consequently, they lose mobility and struggle with daily activities. Moreover, advanced disease can cause permanent spinal fusion and reduced work capacity.
As a result, many patients face unemployment, financial stress, and poor quality of life. Studies show that late diagnosis leads to higher disability rates and worse long-term outcomes.
Researchers and doctors now stress the need for better awareness programs. Additionally, they recommend training general physicians to recognize warning signs early.
Early diagnosis and timely treatment with biologics can greatly improve patient outcomes. Therefore, India must focus on reducing diagnostic delays through better healthcare access and education.
This topic offers excellent opportunities for research using patient registries, surveys, and clinical data.